Life sciences is a fast-growing economic sector, driven by multiple factors, including an ageing population and the increasing demand for advanced healthcare treatments and drugs.

The term “life sciences” is very broad and is typically defined as the sciences concerned with the study of living organisms. It encompasses pharmaceuticals, medical devices and biotech. In Europe, health expenditures as a percentage of GDP can be as high as 12.7 percent (in Germany), and health expenditure per capita is growing by 3.3 percent more than inflation across the member countries in the OECD. This growth has significant implications for the real estate sector, with demand rising for different type of facilities, including laboratories, incubators, accelerators, clinics, manufacturing facilities and cold chain distribution, to name just a few.

In response, the landscape of life sciences real estate in Europe is witnessing a material expansion, marked by increasing numbers of dea